Cutaneous Melanoma

Long-Term Trials Indicate that Smaller Resection Margins Don't Compromise Results

Published in Cancer Weekly, October 24th, 2000

Study results from a multicenter, long-term, randomized trial published in the October 1, 2000, issue of Cancer show that melanoma patients with a tumor thickness of > 0.8 mm and {{<=}} 2.0 mm, treated with a resection margin of 2 cm, experience the same results as patients treated with a resection margin of 5 cm.

"If the extent of surgery can be reduced without compromising the survival of the patient, then both society and the patients will benefit," comment chief researcher Gabriella Cohn-Cedermark, MD, PhD, and colleagues from the Department of Oncology and Pathology at Karolinska Hospital in Stockholm, Sweden.

No differences in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2000-10-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry